Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

被引:11
作者
Chammartin, Frederique [1 ]
Kusejko, Katharina [2 ,3 ,4 ]
Pasin, Chloe [4 ]
Trkola, Alexandra [4 ]
Briel, Matthias [1 ]
Amico, Patrizia [5 ]
Stoekle, Marcel P. [6 ]
Eichenberger, Anna L. [7 ]
Hasse, Barbara [3 ]
Braun, Dominique L. [4 ]
Schuurmans, Mace M. [8 ]
Mueller, Thomas F.
Tamm, Michael [10 ]
Mueller, Nicolas J. [2 ,3 ,9 ]
Rauch, Andri
Koller, Michael T. [11 ,12 ]
Guenthard, Huldrych F. [3 ,4 ]
Bucher, Heiner C. [1 ]
Speich, Benjamin [1 ]
Abela, Irene A. [2 ,3 ]
机构
[1] Univ Basel, Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Spitalstr12, CH-4056 Basel, Switzerland
[2] Univ Hosp Zurich, Div Infect Dis, Zurich, Switzerland
[3] Univ Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland
[4] Univ Zurich, Inst Med Virol, Zurich, Switzerland
[5] Univ Basel, Clin Transplantat Immunol & Nephrol, Basel, Switzerland
[6] Univ Basel, Univ Basel Hosp, Div Infectious Dis, Basel, Switzerland
[7] Univ Basel, Hosp Epidemiol, Basel, Switzerland
[8] Univ Bern, Univ Hosp Bern, Inselspital, Dept Infect Dis, Bern, Switzerland
[9] Univ Hosp Zurich, Div Pulmonol, Zurich, Switzerland
[10] Univ Hosp Zurich, Nephrol Clin, Zurich, Switzerland
[11] Univ Basel, Univ Basel Hosp, Clin Resp Med & Pulm Cell Res, Basel, Switzerland
[12] Univ Basel, Univ Basel Hosp, Swiss Transplant Cohort Study, Basel, Switzerland
基金
瑞士国家科学基金会;
关键词
VACCINATION; SARS-COV-2; SAFETY;
D O I
10.1097/QAD.0000000000003246
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We identified determinants of SARS-CoV-2 mRNA vaccine antibody response in people with HIV (PWH). Antibody response was higher among PWH less than 60 years, with CD4(+) cell count superior to 350 cells/mu l and vaccinated with mRNA-1273 by Moderna compared with BNT162b2 by Pfizer-BioNTech. Preinfection with SARS-CoV-2 boosted the antibody response and smokers had an overall lower antibody response. Elderly PWH and those with low CD4(+) cell count should be prioritized for booster vaccinations.
引用
收藏
页码:1465 / 1468
页数:4
相关论文
共 23 条
[1]  
Abela Irene A, 2021, Nat Commun, V12, P1
[2]   Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar [J].
Abu-Raddad, L. J. ;
Chemaitelly, H. ;
Ayoub, H. H. ;
AlMukdad, S. ;
Yassine, H. M. ;
Al-Khatib, H. A. ;
Smatti, M. K. ;
Tang, P. ;
Hasan, M. R. ;
Coyle, P. ;
Al-Kanaani, Z. ;
Al-Kuwari, E. ;
Jeremijenko, A. ;
Kaleeckal, A. H. ;
Latif, A. N. ;
Shaik, R. M. ;
Abdul-Rahim, H. F. ;
Nasrallah, G. K. ;
Al-Kuwari, M. G. ;
Butt, A. A. ;
Al-Romaihi, H. E. ;
Al-Thani, M. H. ;
Al-Khal, A. ;
Bertollini, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19) :1804-1816
[3]   SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine [J].
Anderson, Mark ;
Stec, Michael ;
Rewane, Ayesan ;
Landay, Alan ;
Cloherty, Gavin ;
Moy, James .
JAMA NETWORK OPEN, 2021, 4 (08)
[4]   Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant [J].
Arien, Kevin K. ;
Heyndrickx, Leo ;
Michiels, Johan ;
Vereecken, Katleen ;
Van Lent, Kurt ;
Coppens, Sandra ;
Willems, Betty ;
Pannus, Pieter ;
Martens, Geert A. ;
Van Esbroeck, Marjan ;
Goossens, Maria E. ;
Marchant, Arnaud ;
Bartholomeeusen, Koen ;
Desombere, Isabelle .
NPJ VACCINES, 2022, 7 (01)
[5]  
Brumme Zabrina L, 2021, medRxiv, DOI 10.1101/2021.10.03.21264320
[6]   Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study [J].
del Amo, Julia ;
Polo, Rosa ;
Moreno, Santiago ;
Diaz, Asuncion ;
Martinez, Esteban ;
Ramon Arribas, Jose ;
Jarrin, Inma ;
Hernan, Miguel A. .
ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) :536-+
[7]   The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies [J].
Ferrara, Pietro ;
Gianfredi, Vincenza ;
Tomaselli, Venera ;
Polosa, Riccardo .
VACCINES, 2022, 10 (02)
[8]   Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine [J].
Frasca, Daniela ;
Diaz, Alain ;
Romero, Maria ;
Landin, Ana Marie ;
Blomberg, Bonnie B. .
VACCINE, 2015, 33 (12) :1433-1439
[9]   Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial [J].
Frater, John ;
Ewer, Katie J. ;
Ogbe, Ane ;
Pace, Mathew ;
Adele, Sandra ;
Adland, Emily ;
Alagaratnam, Jasmini ;
Aley, Parvinder K. ;
Ali, Mohammad ;
Ansari, M. Azim ;
Bara, Anna ;
Bittaye, Mustapha ;
Broadhead, Samantha ;
Brown, Anthony ;
Brown, Helen ;
Cappuccini, Federica ;
Cooney, Enya ;
Dejnirattisai, Wanwisa ;
Dold, Christina ;
Fairhead, Cassandra ;
Fok, Henry ;
Folegatti, Pedro M. ;
Fowler, Jamie ;
Gibbs, Charlotte ;
Goodman, Anna L. ;
Jenkin, Daniel ;
Jones, Mathew ;
Makinson, Rebecca ;
Marchevsky, Natalie G. ;
Mujadidi, Yama F. ;
Nguyen, Hanna ;
Parolini, Lucia ;
Petersen, Claire ;
Plested, Emma ;
Pollock, Katrina M. ;
Ramasamy, Maheshi N. ;
Rhead, Sarah ;
Robinson, Hannah ;
Robinson, Nicola ;
Rongkard, Patpong ;
Ryan, Fiona ;
Serrano, Sonia ;
Tipoe, Timothy ;
Voysey, Merryn ;
Waters, Anele ;
Zacharopoulou, Panagiota ;
Barnes, Eleanor ;
Dunachie, Susanna ;
Goulder, Philip ;
Klenerman, Paul .
LANCET HIV, 2021, 8 (08) :E474-E485
[10]   Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients [J].
Kamar, Nassim ;
Abravanel, Florence ;
Marion, Olivier ;
Couat, Chloe ;
Izopet, Jacques ;
Del Bello, Arnaud .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) :661-662